PerkinElmer,
Inc., a global leader focused on improving the health and safety of
people and the environment, announced that its electronic
laboratory notebook (ELN) can now be seamlessly integrated with Elsevier’s
Reaxys®, a web-based workflow solution designed for
chemistry researchers in drug discovery, chemicals and academic research.
Screenshot of E-Notebook interface with a result from Reaxys (Graphic: Business Wire)
“As chemists are increasingly turning to electronic laboratory notebooks
to plan, execute and record their experiments, they also need ready
access to complementary tools and data sources directly within the ELN
interface,” said Michael Stapleton, general manager, PerkinElmer
Informatics. “The interoperability of our ELN and Elsevier’s Reaxys
provides researchers with access to extensive information on chemical
compounds and related physical and pharmacological properties so that
they can make better decisions. This integration also allows researchers
to save valuable time by providing the ability to rapidly search and
import external data while eliminating transcription errors.”
Capturing Reaxys content through PerkinElmer’s ELN gives researchers the
power to simultaneously leverage information from both sources in order
to make critical decisions throughout the chemistry research workflow.
Chemical searches in Reaxys can be initiated in an experimental section
in the ELN, based on existing or newly drawn compounds or reactions, and
results are immediately available. Once suitable reactions are located
and selected in Reaxys, they can be exported directly to the ELN and
inserted into a pre-designed experiment, complete with reaction scheme,
stoichiometry table and preparation text.
PerkinElmer and Elsevier will host an informative workshop at the American
Chemical Society in Philadelphia, PA on August 20th at
8:30 am ET to demonstrate and discuss the benefits of integrating Reaxys
and PerkinElmer’s ELN. To register for the workshop, signup here.
Integrating the ELN with Reaxys is available at no extra charge to
customers who already have both systems.
PerkinElmer is a leading provider of discovery, collaboration, and
knowledge enterprise solutions, desktop software, scientific databases
and consulting services to the pharmaceutical, biotechnology, and
chemical industries. The Company offers enterprise solutions, desktop
software, scientific databases, and professional services for
biotechnology, drug discovery and chemical research, including software,
databases, and web sites which enable customers to create, analyze and
communicate chemical, biological, and scientific information more
effectively. Learn about our informatics solutions at www.perkinelmer.com/informatics.
Reaxys® and the Reaxys® trademark are owned and
protected by Reed Elsevier Properties SA. All rights reserved.
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and
safety of people and the environment. The company reported revenue of
approximately $1.9 billion in 2011, has about 7,000 employees serving
customers in more than 150 countries, and is a component of the S&P 500
Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50380171&lang=en

cliquer sur l'image pour l'agrandir
Source(s) : PerkinElmer, Inc.